1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Paresthesia: new trials by email Literature Review of Paresthesia trials Research Report on Paresthesia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers AZD3161, Lidocaine, AZD3161 Placebo - Peripheral Neuropathic Pain, Nociceptive Pain | Phase 1 | Completed | AstraZeneca | 26 | 2010-12-01 | 2011-04-12 |
Hyperalgesia (1) · Nociceptive Pain (1)
Nervous System Diseases (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Somatosensory Disorders (1)
Lidocaine (1)
AstraZeneca (1)
United Kingdom (1)
Bo Fransson (1) · Darren Wilbraham, MD, MBBS DCPSA (1)